Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Assets Average (2016 - 2025)

Enanta Pharmaceuticals' Assets Average history spans 13 years, with the latest figure at $305.1 million for Q4 2025.

  • For Q4 2025, Assets Average fell 15.86% year-over-year to $305.1 million; the TTM value through Dec 2025 reached $305.1 million, down 15.86%, while the annual FY2025 figure was $328.7 million, 21.64% down from the prior year.
  • Assets Average reached $305.1 million in Q4 2025 per ENTA's latest filing, up from $290.9 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $478.7 million in Q3 2023 to a low of $290.9 million in Q3 2025.
  • Average Assets Average over 5 years is $393.6 million, with a median of $401.1 million recorded in 2022.
  • Peak YoY movement for Assets Average: grew 25.88% in 2023, then fell 24.98% in 2025.
  • A 5-year view of Assets Average shows it stood at $439.7 million in 2021, then dropped by 17.79% to $361.5 million in 2022, then increased by 23.21% to $445.4 million in 2023, then fell by 18.58% to $362.6 million in 2024, then decreased by 15.86% to $305.1 million in 2025.
  • Per Business Quant, the three most recent readings for ENTA's Assets Average are $305.1 million (Q4 2025), $290.9 million (Q3 2025), and $312.0 million (Q2 2025).